|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 50, Issue 5 312-336, Copyright © 2000 by American Cancer Society
R. A. Smith
In the hope of resolving underlying policy questions related to the value
of breast cancer screening with mammography for women younger than 50 years
of age, the National Institutes of Health and the National Cancer Institute
in 1997 jointly sponsored a consensus conference on the subject. While the
panel concluded that the data were insufficient to endorse mammography for
this age group apart from individual choice, the conclusion was not the
"consensus" sought by many of those with strong opinions on both sides of
this issue, and the debate raged on. Prior to the 1997 conference, and
since, meta-analyses of trial data and assessments of service screening
programs have indicated that breast cancer screening with mammography for
women between 40 and 49 meets recommended levels of performance compared
with performance in women 50 years and older, especially if programs
achieve high quality and screen at 12-to-18 month intervals. Because the
detectable preclinical phase is shorter in younger women who develop breast
cancer compared with that in women 50 years of age or older, a key
component of any screening program for those younger than 50 is an
appropriate screening interval. Many of the screening programs that had
historically been developed for women in their forties--and whose
disappointing results contributed to the confusion and controversy about
the efficacy of mammography in younger women--had a 24-month screening
interval, which was not found to be of significant benefit for early
detection of breast cancer in this age group. While a new emphasis of this
controversy has focused on the balance of benefits and harms in women ages
40 to 49, women of all ages need to be fully informed about the benefits
and limitations of breast cancer screening--more specifically, what to
expect at the time of screening, and what to expect from screening. There
are differences in the performance and effectiveness of mammography in
different age groups of women aged 40 and older, but these differences are
not so great to question the value of screening in any one group. While
some questions remain unresolved, the efficacy of mammography in women ages
40 to 49 should no longer be considered controversial.
ARTICLES
Breast cancer screening among women younger than age 50: a current assessment of the issues
American Cancer Society, Atlanta, GA, USA.
This article has been cited by other articles:
![]() |
C. M. Hakim, D. M. Chough, M. A. Ganott, J. H. Sumkin, M. L. Zuley, and D. Gur Digital Breast Tomosynthesis in the Diagnostic Environment: A Subjective Side-by-Side Review Am. J. Roentgenol., August 1, 2010; 195(2): W172 - W176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M Reis, M Tavakoli, J Dewar, D Goudie, A Cook, L McLeish, D Young, J Kenyon, and M Steel Evaluation of a surveillance programme for women with a family history of breast cancer J. Med. Genet., May 1, 2009; 46(5): 319 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Jafri, R. S. Ayyala, A. Ozonoff, J. Jordan-Gray, and P. J. Slanetz Screening Mammography: Does Ethnicity Influence Patient Preferences for Higher Recall Rates Given the Potential for Earlier Detection of Breast Cancer? Radiology, December 1, 2008; 249(3): 785 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Armstrong, E. Moye, S. Williams, J. A. Berlin, and E. E. Reynolds Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 516 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ganott, J. H. Sumkin, J. L. King, A. H. Klym, V. J. Catullo, C. S. Cohen, and D. Gur Screening Mammography: Do Women Prefer a Higher Recall Rate Given the Possibility of Earlier Detection of Cancer? Radiology, March 1, 2006; 238(3): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. M. Buist, P. L. Porter, C. Lehman, S. H. Taplin, and E. White Factors Contributing to Mammography Failure in Women Aged 40-49 Years J Natl Cancer Inst, October 6, 2004; 96(19): 1432 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Weir, M. J. Thun, B. F. Hankey, L. A. G. Ries, H. L. Howe, P. A. Wingo, A. Jemal, E. Ward, R. N. Anderson, and B. K. Edwards Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control J Natl Cancer Inst, September 3, 2003; 95(17): 1276 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Garber Breast Cancer Screening: A Final Analysis? CA Cancer J Clin, May 1, 2003; 53(3): 138 - 140. [Full Text] [PDF] |
||||
![]() |
R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith An Overview of Mammography: Benefits and Limitations J Natl Compr Canc Netw, April 1, 2003; 1(2): 264 - 271. [Abstract] [PDF] |
||||
![]() |
J. H. Sumkin, B. L. Holbert, J. S. Herrmann, C. A. Hakim, M. A. Ganott, W. R. Poller, R. Shah, L. A. Hardesty, and D. Gur Optimal Reference Mammography: A Comparison of Mammograms Obtained 1 and 2 Years Before the Present Examination Am. J. Roentgenol., February 1, 2003; 180(2): 343 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Berlin Dot Size, Lead Time, Fallibility, and Impact on Survival: Continuing Controversies in Mammography Am. J. Roentgenol., May 1, 2001; 176(5): 1123 - 1130. [Full Text] [PDF] |
||||
![]() |
B. Zheng, M. A. Ganott, C. A. Britton, C. M. Hakim, L. A. Hardesty, T. S. Chang, H. E. Rockette, and D. Gur Soft-Copy Mammographic Readings with Different Computer-assisted Detection Cuing Environments: Preliminary Findings Radiology, December 1, 2001; 221(3): 633 - 640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |